Search research articles
Contact Us
Filters
Showing results (341-350 of 398) with videos related to
Page
of 40
Sort By:
Nuclear Medicine Communications
|
November 14, 1997
Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients
S A McQuarrie, R P Baum, A Niesen, et al.
Clinical Nuclear Medicine
|
October 14, 2015
Localization of Radiolabeled Somatostatin Analogs in the Spleen
Marleen Melis, Daniel Kaemmerer, Jan de Swart, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 3, 2010
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
Irene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2015
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
L Bodei, M Kidd, I M Modlin, et al.
European Journal of Nuclear Medicine
|
January 1, 1990
Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments
A Chetanneau, R P Baum, P A Lehur, et al.
EJNMMI Research
|
May 25, 2019
Instant kit preparation of <sup>68</sup>Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [<sup>68</sup>Ga]Ga-DATA-TOC
Jean-Philippe Sinnes, Johannes Nagel, Bradley P Waldron, et al.
International Journal of Medical Sciences
|
April 16, 2021
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms
Andrea Frilling, Ashley K Clift, Adam E Frampton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 20, 2015
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen, Margret Schottelius, Jakub Simecek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
Berthold A Nock, Aikaterini Kaloudi, Emmanouil Lymperis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Lisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
Page
of 40
Search research articles
Search
Showing results (341-350 of 398) with videos related to
Sort By:
Page
of 40
Nuclear Medicine Communications
|
November 14, 1997
Pharmacokinetics and radiation dosimetry of 99Tcm-labelled monoclonal antibody B43.13 in ovarian cancer patients
S A McQuarrie, R P Baum, A Niesen, et al.
Clinical Nuclear Medicine
|
October 14, 2015
Localization of Radiolabeled Somatostatin Analogs in the Spleen
Marleen Melis, Daniel Kaemmerer, Jan de Swart, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 3, 2010
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE
Irene Virgolini, Valentina Ambrosini, Jamshed B Bomanji, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2015
Gene transcript analysis blood values correlate with ⁶⁸Ga-DOTA-somatostatin analog (SSA) PET/CT imaging in neuroendocrine tumors and can define disease status
L Bodei, M Kidd, I M Modlin, et al.
European Journal of Nuclear Medicine
|
January 1, 1990
Multi-centre immunoscintigraphic study using indium-111-labelled CEA-specific and/or 19-9 monoclonal antibody F(ab')2 fragments
A Chetanneau, R P Baum, P A Lehur, et al.
EJNMMI Research
|
May 25, 2019
Instant kit preparation of <sup>68</sup>Ga-radiopharmaceuticals via the hybrid chelator DATA: clinical translation of [<sup>68</sup>Ga]Ga-DATA-TOC
Jean-Philippe Sinnes, Johannes Nagel, Bradley P Waldron, et al.
International Journal of Medical Sciences
|
April 16, 2021
A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms
Andrea Frilling, Ashley K Clift, Adam E Frampton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 20, 2015
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
Martina Weineisen, Margret Schottelius, Jakub Simecek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 6, 2016
Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results
Berthold A Nock, Aikaterini Kaloudi, Emmanouil Lymperis, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors
Lisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
Page
of 40